Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SanoOptic
- Development stage
- Unknown
- Lead developer
- BioXtek
- Administration
- Ophthalmic
01
Overview
SanoOptic is a sterile, single-layer amniotic membrane allograft (HCT/P allograft) developed by BioXtek for ophthalmic applications. Designed as a 10mm eye patch, it serves as a protective wound covering and extracellular matrix scaffold to support native tissue healing on the ocular surface. The allograft is derived from prescreened mothers with healthy, non-emergent deliveries, minimally manipulated to preserve the native structure of the tissue, and terminally sterilized. It utilizes BioXtek's proprietary BioPür process to ensure a cell-free, stable extracellular matrix that adheres easily to the ocular surface, making it particularly suitable for treating dry eye syndrome and other ocular surface conditions.
- Brand names
- SanoOptic
- Other names
- SanoOptic (eye patches)SanoOptic eye patches
Beyond the preview
Go deeper on SanoOptic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SanoOptic.